Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297087 · ClinicalTrials.gov registry record · NA
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
A NA study, sponsored by Western Regional Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02297087: Clinical Trial NA study, sponsored by Western Regional Medical Center.
NCT02297087 is a NA study that was terminated before completion, run by Western Regional Medical Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02297087, a NA study, was terminated before completion, sponsored by Western Regional Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Aim 1 - Launch Pilot Study. In this aim, the investigators seek to launch a pilot study and enroll 12 eligible patients with advanced small cell lung cancer (SCLC) and to obtain the necessary tumor biopsies to yield sufficient DNA and RNA for Genome-Wide Sequencing (GWS). Aim 2 - Treatment Selection. Completion of this study aim will provide a new clinical paradigm in the treatment of SCLC such that each individual patient would be treated with a single-agent or combination therapy of commercially available agents that relates to particular target(s) that have been identified via GWS.
Interventions
- GENETIC Standard of care based on target(s) identified via GWS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02297087
The ClinicalTrials.gov registry entry for NCT02297087 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Western Regional Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of care based on target(s) identified via GWS. is the first listed.
NCT02297087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02297087 about?
NCT02297087 is a clinical study titled "Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment". Aim 1 - Launch Pilot Study. In this aim, the investigators seek to launch a pilot study and enroll 12 eligible patients with advanced small cell lung cancer (SCLC) and to obtain the necessary tumor biopsies to yield sufficient DNA and RNA for Genome-Wide Sequencing (GWS). Aim 2 - Treatment Selectio...
What is the current status of trial NCT02297087?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2014-10. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02297087?
The interventions under investigation include: Standard of care based on target(s) identified via GWS. (GENETIC).
Who is sponsoring clinical trial NCT02297087?
This trial is sponsored by Western Regional Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.